Democratic VP Nominee Edwards Bolsters Kerry’s “Affordable Health Care” Agenda
This article was originally published in The Pink Sheet Daily
Sen. Edwards is an advocate of stricter DTC regulation, generic patent law reform, comparative effectiveness research and DoJ investigation of manufacturer “price gouging.”
You may also be interested in...
Statutory language prohibiting HHS from negotiating prices with drug manufacturers will likely be repealed in the next two years regardless of the presidential election's outcome, Patton Boggs partner Kathleen Means says.
The private sector is unlikely to offer stand-alone drug insurance plans under Medicare in 2006, Medco CEO David Snow predicted during the Goldman Sachs conference in Laguna Niguel, Calif. June 9
The legislation is similar to an amendment Edwards proposed for the Medicare Rx bill. It also calls for NIH comparative efficacy studies and an expedited drug advertisement review process.